Overview

Protocol for Women at Increased Risk of Developing Breast Cancer

Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
A pilot study to assess the effects of six months of letrozole on breast tissue risk markers in postmenopausal women on hormone replacement therapy at high risk of developing breast cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Carol Fabian, MD
Collaborator:
Novartis
Treatments:
Letrozole